Thus, it is plausible that the systemic production of high levels of pro-inflammatory mediators such as TNF-α and IFN-γ in response to infection with the SARS-Cov-2 virus could accelerate the neurodegeneration in patients with concurrent prion disease or other neurodegenerative disorders. The gene discussed is IFNG; the disease is infection.